NBAS_HUMAN - dbPTM
NBAS_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NBAS_HUMAN
UniProt AC A2RRP1
Protein Name Neuroblastoma-amplified sequence
Gene Name NBAS
Organism Homo sapiens (Human).
Sequence Length 2371
Subcellular Localization Cytoplasm . Endoplasmic reticulum . Endoplasmic reticulum membrane
Peripheral membrane protein .
Protein Description Involved in Golgi-to-endoplasmic reticulum (ER) retrograde transport; the function is proposed to depend on its association in the NRZ complex which is believed to play a role in SNARE assembly at the ER. [PubMed: 19369418]
Protein Sequence MAAPESGPALSPGTAEGEEETILYDLLVNTEWPPETEVQPRGNQKHGASFIITKAIRDRLLFLRQYIWYSPAPFLLPDGLVRLVNKQINWHLVLASNGKLLAAVQDQCVEIRSAKDDFTSIIGKCQVPKDPKPQWRRVAWSYDCTLLAYAESTGTVRVFDLMGSELFVISPASSFIGDLSYAIAGLIFLEYKASAQWSAELLVINYRGELRSYLVSVGTNQSYQESHCFSFSSHYPHGINTAIYHPGHRLLLVGGCETAEVGMSKASSCGLSAWRVLSGSPYYKQVTNGGDGVTAVPKTLGLLRMLSVKFYSRQGQEQDGIFKMSLSPDGMLLAAIHFSGKLSIWAIPSLKQQGEWGQNEQPGYDDLNPDWRLSTEKRKKIKDKESFYPLIDVNWWADSAVTLARCSGALTVSSVKTLKNLLGKSCEWFEPSPQVTATHDGGFLSLECEIKLAPKRSRLETRAGEEDEGEEDSDSDYEISAKARYFGYIKQGLYLVTEMERFAPPRKRPRTITKNYRLVSLRSTTPEELYQRKIESEEYEEALSLAHTYGLDTDLVYQRQWRKSAVNVASIQNYLSKIKKRSWVLHECLERVPENVDAAKELLQYGLKGTDLEALLAIGKGADDGRFTLPGEIDIDSISYEELSPPDEEPAKNKKEKELKKRQELLKLVNFSKLTLEQKELCRCRRKLLTYLDRLATYEEILGVPHASEQRYDAEFFKKFRNQNIVLSARTYAQESNVQALEILFTYHGSDLLPHRLAILSNFPETTSPHEYSVLLPEACFNGDSLMIIPWHEHKHRAKDWCEELACRMVVEPNLQDESEFLYAAQPELLRFRMTQLTVEKVMDWYQTRAEEIEHYARQVDCALSLIRLGMERNIPGLLVLCDNLVTLETLVYEARCDVTLTLKELQQMKDIEKLRLLMNSCSEDKYVTSAYQWMVPFLHRCEKQSPGVANELLKEYLVTLAKGDLKFPLKIFQHSKPDLQQKIIPDQDQLMAIALECIYTCERNDQLCLCYDLLECLPERGYGDKTEATTKLHDMVDQLEQILSVSELLEKHGLEKPISFVKNTQSSSEEARKLMVRLTRHTGRKQPPVSESHWRTLLQDMLTMQQNVYTCLDSDACYEIFTESLLCSSRLENIHLAGQMMHCSACSENPPAGIAHKGKPHYRVSYEKSIDLVLAASREYFNSSTNLTDSCMDLARCCLQLITDRPPAIQEELDLIQAVGCLEEFGVKILPLQVRLCPDRISLIKECISQSPTCYKQSTKLLGLAELLRVAGENPEERRGQVLILLVEQALRFHDYKAASMHCQELMATGYPKSWDVCSQLGQSEGYQDLATRQELMAFALTHCPPSSIELLLAASSSLQTEILYQRVNFQIHHEGGENISASPLTSKAVQEDEVGVPGSNSADLLRWTTATTMKVLSNTTTTTKAVLQAVSDGQWWKKSLTYLRPLQGQKCGGAYQIGTTANEDLEKQGCHPFYESVISNPFVAESEGTYDTYQHVPVESFAEVLLRTGKLAEAKNKGEVFPTTEVLLQLASEALPNDMTLALAYLLALPQVLDANRCFEKQSPSALSLQLAAYYYSLQIYARLAPCFRDKCHPLYRADPKELIKMVTRHVTRHEHEAWPEDLISLTKQLHCYNERLLDFTQAQILQGLRKGVDVQRFTADDQYKRETILGLAETLEESVYSIAISLAQRYSVSRWEVFMTHLEFLFTDSGLSTLEIENRAQDLHLFETLKTDPEAFHQHMVKYIYPTIGGFDHERLQYYFTLLENCGCADLGNCAIKPETHIRLLKKFKVVASGLNYKKLTDENMSPLEALEPVLSSQNILSISKLVPKIPEKDGQMLSPSSLYTIWLQKLFWTGDPHLIKQVPGSSPEWLHAYDVCMKYFDRLHPGDLITVVDAVTFSPKAVTKLSVEARKEMTRKAIKTVKHFIEKPRKRNSEDEAQEAKDSKVTYADTLNHLEKSLAHLETLSHSFILSLKNSEQETLQKYSHLYDLSRSEKEKLHDEAVAICLDGQPLAMIQQLLEVAVGPLDISPKDIVQSAIMKIISALSGGSADLGGPRDPLKVLEGVVAAVHASVDKGEELVSPEDLLEWLRPFCADDAWPVRPRIHVLQILGQSFHLTEEDSKLLVFFRTEAILKASWPQRQVDIADIENEENRYCLFMELLESSHHEAEFQHLVLLLQAWPPMKSEYVITNNPWVRLATVMLTRCTMENKEGLGNEVLKMCRSLYNTKQMLPAEGVKELCLLLLNQSLLLPSLKLLLESRDEHLHEMALEQITAVTTVNDSNCDQELLSLLLDAKLLVKCVSTPFYPRIVDHLLASLQQGRWDAEELGRHLREAGHEAEAGSLLLAVRGTHQAFRTFSTALRAAQHWV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure		 ASA (%) Reference Orthologous
Protein Cluster
11PhosphorylationPESGPALSPGTAEGE
CCCCCCCCCCCCCCC		24.3225159151
14PhosphorylationGPALSPGTAEGEEET
CCCCCCCCCCCCCEE		25.5625627689
21PhosphorylationTAEGEEETILYDLLV
CCCCCCEEEEEEEHH		21.4025627689
45UbiquitinationVQPRGNQKHGASFII
CCCCCCCCCCCEEEE		48.26-
49PhosphorylationGNQKHGASFIITKAI
CCCCCCCEEEEEHHH		22.9030108239
115UbiquitinationCVEIRSAKDDFTSII
HHHHHHCCCCCHHHH		60.1121906983
115 (in isoform 1)Ubiquitination-60.1121906983
115 (in isoform 2)Ubiquitination-60.1121906983
265UbiquitinationTAEVGMSKASSCGLS
CCCCCCCHHHHCCCC		43.31-
284AcetylationLSGSPYYKQVTNGGD
HCCCCCCEECCCCCC		32.2326051181
284UbiquitinationLSGSPYYKQVTNGGD
HCCCCCCEECCCCCC		32.23-
294PhosphorylationTNGGDGVTAVPKTLG
CCCCCCCCCCCHHHH		27.71-
307PhosphorylationLGLLRMLSVKFYSRQ
HHHHHHHHHEEECCC		17.5823882029
327PhosphorylationGIFKMSLSPDGMLLA
CEEEEEECCCCCEEE		17.4022210691
339PhosphorylationLLAAIHFSGKLSIWA
EEEEEEECCCEEEEE		22.3622210691
343PhosphorylationIHFSGKLSIWAIPSL
EEECCCEEEEECCCH		21.4123403867
349PhosphorylationLSIWAIPSLKQQGEW
EEEEECCCHHHCCCC		41.9324719451
386PhosphorylationKKIKDKESFYPLIDV
HCCCCHHHCCCCCCC		35.5020860994
388PhosphorylationIKDKESFYPLIDVNW
CCCHHHCCCCCCCCC		13.3527470641
399PhosphorylationDVNWWADSAVTLARC
CCCCCCCHHHHHHHH		19.5220860994
402PhosphorylationWWADSAVTLARCSGA
CCCCHHHHHHHHCCC		17.8920860994
416UbiquitinationALTVSSVKTLKNLLG
CCCHHHHHHHHHHHC		50.52-
417PhosphorylationLTVSSVKTLKNLLGK
CCHHHHHHHHHHHCC		40.5920860994
419UbiquitinationVSSVKTLKNLLGKSC
HHHHHHHHHHHCCCC		51.27-
424UbiquitinationTLKNLLGKSCEWFEP
HHHHHHCCCCEECCC		52.48-
473PhosphorylationEDEGEEDSDSDYEIS
CCCCCCCCCCCCCHH		42.1523927012
475PhosphorylationEGEEDSDSDYEISAK
CCCCCCCCCCCHHHH		46.1525159151
477PhosphorylationEEDSDSDYEISAKAR
CCCCCCCCCHHHHHH		21.0823927012
480PhosphorylationSDSDYEISAKARYFG
CCCCCCHHHHHHHHH		16.2723927012
482UbiquitinationSDYEISAKARYFGYI
CCCCHHHHHHHHHHH		26.97-
485PhosphorylationEISAKARYFGYIKQG
CHHHHHHHHHHHHCC		13.25-
488PhosphorylationAKARYFGYIKQGLYL
HHHHHHHHHHCCEEH		8.61-
490UbiquitinationARYFGYIKQGLYLVT
HHHHHHHHCCEEHHE		29.81-
494PhosphorylationGYIKQGLYLVTEMER
HHHHCCEEHHEEHHH		13.12-
497PhosphorylationKQGLYLVTEMERFAP
HCCEEHHEEHHHCCC		27.33-
511PhosphorylationPPRKRPRTITKNYRL
CCCCCCCCCCCCCEE		35.3620068231
513PhosphorylationRKRPRTITKNYRLVS
CCCCCCCCCCCEEEE		16.7820068231
520PhosphorylationTKNYRLVSLRSTTPE
CCCCEEEECCCCCHH		23.7424719451
525PhosphorylationLVSLRSTTPEELYQR
EEECCCCCHHHHHHH		29.9223917254
533UbiquitinationPEELYQRKIESEEYE
HHHHHHHHCCCHHHH		34.99-
539PhosphorylationRKIESEEYEEALSLA
HHCCCHHHHHHHHHH		18.28-
549PhosphorylationALSLAHTYGLDTDLV
HHHHHHHHCCCHHHH		13.06-
557PhosphorylationGLDTDLVYQRQWRKS
CCCHHHHHHHHHHHH		12.79-
563UbiquitinationVYQRQWRKSAVNVAS
HHHHHHHHHCCHHHH		39.55-
564PhosphorylationYQRQWRKSAVNVASI
HHHHHHHHCCHHHHH		28.9528348404
577UbiquitinationSIQNYLSKIKKRSWV
HHHHHHHHHHHHHHH		56.82-
579UbiquitinationQNYLSKIKKRSWVLH
HHHHHHHHHHHHHHH		45.96-
600UbiquitinationPENVDAAKELLQYGL
CCCHHHHHHHHHHCC		51.09-
620UbiquitinationEALLAIGKGADDGRF
HHHHHHCCCCCCCCC		44.83-
639PhosphorylationEIDIDSISYEELSPP
CEECCCCCHHHCCCC		30.3728796482
640PhosphorylationIDIDSISYEELSPPD
EECCCCCHHHCCCCC		16.2628796482
673UbiquitinationLKLVNFSKLTLEQKE
HHHHCHHHCCHHHHH		41.16-
679MalonylationSKLTLEQKELCRCRR
HHCCHHHHHHHHHHH		43.1926320211
679UbiquitinationSKLTLEQKELCRCRR
HHCCHHHHHHHHHHH		43.19-
679 (in isoform 1)Ubiquitination-43.1921906983
679 (in isoform 2)Ubiquitination-43.1921906983
687UbiquitinationELCRCRRKLLTYLDR
HHHHHHHHHHHHHHH		28.61-
698PhosphorylationYLDRLATYEEILGVP
HHHHHHCHHHHHCCC		13.1227642862
708PhosphorylationILGVPHASEQRYDAE
HHCCCCCCCCCCCHH		31.0922210691
712PhosphorylationPHASEQRYDAEFFKK
CCCCCCCCCHHHHHH		21.1422210691
799UbiquitinationHEHKHRAKDWCEELA
CCCCHHCHHHHHHHH		52.28-
841UbiquitinationMTQLTVEKVMDWYQT
HCHHHHHHHHHHHHH		38.22-
856PhosphorylationRAEEIEHYARQVDCA
HHHHHHHHHHHHHHH		7.2427642862
865PhosphorylationRQVDCALSLIRLGME
HHHHHHHHHHHHCCC		11.8324719451
893PhosphorylationVTLETLVYEARCDVT
EEHHHHHHHHCCCEE		13.6422817900
944UbiquitinationPFLHRCEKQSPGVAN
HHHHHHHHCCCCHHH		60.7521906983
944 (in isoform 1)Ubiquitination-60.7521906983
955UbiquitinationGVANELLKEYLVTLA
CHHHHHHHHHHHHHH		57.87-
971UbiquitinationGDLKFPLKIFQHSKP
CCCCCCHHHHCCCCC		41.53-
977UbiquitinationLKIFQHSKPDLQQKI
HHHHCCCCCCHHHCC		40.19-
1027PhosphorylationERGYGDKTEATTKLH
HCCCCCCCHHHHHHH		35.2822964224
1030PhosphorylationYGDKTEATTKLHDMV
CCCCCHHHHHHHHHH		20.4522964224
1052UbiquitinationSVSELLEKHGLEKPI
CHHHHHHHCCCCCCC		42.83-
1057AcetylationLEKHGLEKPISFVKN
HHHCCCCCCCCHHCC		53.3319608861
1057MalonylationLEKHGLEKPISFVKN
HHHCCCCCCCCHHCC		53.3326320211
1057UbiquitinationLEKHGLEKPISFVKN
HHHCCCCCCCCHHCC		53.3319608861
1063UbiquitinationEKPISFVKNTQSSSE
CCCCCHHCCCCCCHH		52.87-
1086UbiquitinationLTRHTGRKQPPVSES
HHHCCCCCCCCCCHH		69.38-
1141 (in isoform 2)Ubiquitination-1.6121906983
1145PhosphorylationAGQMMHCSACSENPP
CHHHCCCHHCCCCCC		20.0324719451
1169UbiquitinationHYRVSYEKSIDLVLA
CCEEEHHHHHHHHHH		44.47-
1243PhosphorylationRLCPDRISLIKECIS
EECCCHHHHHHHHHH		25.5724719451
1246UbiquitinationPDRISLIKECISQSP
CCHHHHHHHHHHCCC		52.40-
1257UbiquitinationSQSPTCYKQSTKLLG
HCCCCHHHHHHHHHH		39.66-
1259PhosphorylationSPTCYKQSTKLLGLA
CCCHHHHHHHHHHHH		24.2927362937
1260PhosphorylationPTCYKQSTKLLGLAE
CCHHHHHHHHHHHHH		24.1827362937
1261AcetylationTCYKQSTKLLGLAEL
CHHHHHHHHHHHHHH		47.1425953088
1261UbiquitinationTCYKQSTKLLGLAEL
CHHHHHHHHHHHHHH		47.142190698
1261 (in isoform 1)Ubiquitination-47.1421906983
1314UbiquitinationLMATGYPKSWDVCSQ
HHHCCCCCHHHHHHH		56.55-
1382PhosphorylationHEGGENISASPLTSK
ECCCCCCCCCCCCCC		33.9921712546
1384PhosphorylationGGENISASPLTSKAV
CCCCCCCCCCCCCCC		17.4128348404
1388PhosphorylationISASPLTSKAVQEDE
CCCCCCCCCCCCCCC		26.7121712546
1410PhosphorylationSADLLRWTTATTMKV
HHHHHHHHCCCHHHH		10.5030576142
1414PhosphorylationLRWTTATTMKVLSNT
HHHHCCCHHHHHCCC		16.7230576142
1419PhosphorylationATTMKVLSNTTTTTK
CCHHHHHCCCCCCHH		34.8120860994
1423PhosphorylationKVLSNTTTTTKAVLQ
HHHCCCCCCHHHHHH		30.3530576142
1433PhosphorylationKAVLQAVSDGQWWKK
HHHHHHHHCCCHHHH		38.7528387310
1440UbiquitinationSDGQWWKKSLTYLRP
HCCCHHHHEEEEEEC		36.66-
1441PhosphorylationDGQWWKKSLTYLRPL
CCCHHHHEEEEEECC		23.4020873877
1443PhosphorylationQWWKKSLTYLRPLQG
CHHHHEEEEEECCCC		27.8320873877
1444PhosphorylationWWKKSLTYLRPLQGQ
HHHHEEEEEECCCCC		13.1527642862
1452UbiquitinationLRPLQGQKCGGAYQI
EECCCCCCCCCEEEE		41.49-
1603UbiquitinationPLYRADPKELIKMVT
CHHCCCHHHHHHHHH		66.74-
1627PhosphorylationAWPEDLISLTKQLHC
CCHHHHHHHHHHHCC		36.9624719451
1643PhosphorylationNERLLDFTQAQILQG
HHHHCCHHHHHHHHH		23.7425690035
16672-HydroxyisobutyrylationFTADDQYKRETILGL
ECCCHHHHHHHHHHH		37.82-
1667UbiquitinationFTADDQYKRETILGL
ECCCHHHHHHHHHHH		37.82-
1801UbiquitinationVASGLNYKKLTDENM
EECCCCCCCCCCCCC		39.99-
1804PhosphorylationGLNYKKLTDENMSPL
CCCCCCCCCCCCCHH		50.5823663014
1809PhosphorylationKLTDENMSPLEALEP
CCCCCCCCHHHHHHH		37.6023663014
1819PhosphorylationEALEPVLSSQNILSI
HHHHHHHCCCCCHHH		30.0623663014
1820PhosphorylationALEPVLSSQNILSIS
HHHHHHCCCCCHHHH		24.0823663014
1825PhosphorylationLSSQNILSISKLVPK
HCCCCCHHHHHHCCC		22.4823663014
1827PhosphorylationSQNILSISKLVPKIP
CCCCHHHHHHCCCCC		19.3023663014
1832UbiquitinationSISKLVPKIPEKDGQ
HHHHHCCCCCCCCCC		64.51-
1842PhosphorylationEKDGQMLSPSSLYTI
CCCCCCCCHHHHHHH		19.86-
1869PhosphorylationLIKQVPGSSPEWLHA
HHCCCCCCCHHHHHH		36.33-
1870PhosphorylationIKQVPGSSPEWLHAY
HCCCCCCCHHHHHHH		32.52-
1877PhosphorylationSPEWLHAYDVCMKYF
CHHHHHHHHHHHHHH		9.73-
1883PhosphorylationAYDVCMKYFDRLHPG
HHHHHHHHHHHCCCC		5.48-
1894PhosphorylationLHPGDLITVVDAVTF
CCCCCEEEEEEEEEE		23.05-
1902PhosphorylationVVDAVTFSPKAVTKL
EEEEEEECHHHHHHC		19.0024719451
1908AcetylationFSPKAVTKLSVEARK
ECHHHHHHCCHHHHH		31.9725953088
1908UbiquitinationFSPKAVTKLSVEARK
ECHHHHHHCCHHHHH		31.97-
1931AcetylationTVKHFIEKPRKRNSE
HHHHHHHCCCCCCCH		45.3523749302
1937PhosphorylationEKPRKRNSEDEAQEA
HCCCCCCCHHHHHHH		50.9225849741
1947PhosphorylationEAQEAKDSKVTYADT
HHHHHHHCCCCHHHH		28.4626074081
1948UbiquitinationAQEAKDSKVTYADTL
HHHHHHCCCCHHHHH		49.05-
1950PhosphorylationEAKDSKVTYADTLNH
HHHHCCCCHHHHHHH		19.4126074081
1951PhosphorylationAKDSKVTYADTLNHL
HHHCCCCHHHHHHHH		12.8826074081
1954PhosphorylationSKVTYADTLNHLEKS
CCCCHHHHHHHHHHH		22.6826074081
1961PhosphorylationTLNHLEKSLAHLETL
HHHHHHHHHHHHHHH		22.7826074081
1975PhosphorylationLSHSFILSLKNSEQE
HCHHHHHHCCCCHHH		32.2624719451
1986UbiquitinationSEQETLQKYSHLYDL
CHHHHHHHHHHHHHC		52.40-
1987PhosphorylationEQETLQKYSHLYDLS
HHHHHHHHHHHHHCC		6.5929759185
1988PhosphorylationQETLQKYSHLYDLSR
HHHHHHHHHHHHCCH		17.6627642862
1991PhosphorylationLQKYSHLYDLSRSEK
HHHHHHHHHCCHHHH		14.9329759185
1998UbiquitinationYDLSRSEKEKLHDEA
HHCCHHHHHHCCCCC		62.49-
2042SulfoxidationDIVQSAIMKIISALS
HHHHHHHHHHHHHHH		2.2621406390
2046PhosphorylationSAIMKIISALSGGSA
HHHHHHHHHHHCCCC		26.9920068231
2049PhosphorylationMKIISALSGGSADLG
HHHHHHHHCCCCCCC		40.6020068231
2052PhosphorylationISALSGGSADLGGPR
HHHHHCCCCCCCCCC		23.3320068231
2204SulfoxidationWVRLATVMLTRCTME
HHHHHHHHHHHHCCC		2.4821406390
2209PhosphorylationTVMLTRCTMENKEGL
HHHHHHHCCCCCCCC		24.9930576142
2213UbiquitinationTRCTMENKEGLGNEV
HHHCCCCCCCCCHHH		39.59-
2255PhosphorylationNQSLLLPSLKLLLES
CHHCHHHHHHHHHHC		37.8024719451
2361PhosphorylationHQAFRTFSTALRAAQ
HHHHHHHHHHHHHHH		16.5028857561
Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of NBAS_HUMAN !!
Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of NBAS_HUMAN !!
Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10) 		Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NBAS_HUMAN !!
Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of NBAS_HUMAN !!
Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
614800Short stature, optic nerve atrophy, and Pelger-Huet anomaly (SOPH)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NBAS_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1057, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-473 AND SER-475, ANDMASS SPECTROMETRY.
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography.";
Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.;
Proteomics 8:1346-1361(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-473 AND SER-475, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-473 AND SER-475, ANDMASS SPECTROMETRY.

TOP
© 2024 Institute of Bioinformatics and Systems Biology, NYCU | Designed by : BiOmics Laboratory